DDX4 and ovarian carcinoma: On the other hand, particularly in the postmenopausal age in which the incidence of the ovarian cancer is significantly higher, the chronic hormone stimulation provided by gonadotropins, such as FSH, may drive the acquisitionof molecular derangements of Ddx4+ cells that contribute to carcinogenesis [33] (Figure 4).